Multi-Omic Biomarkers Improve Indeterminate Pulmonary Nodule Malignancy Risk Assessment

Multi-Omic Biomarkers Improve Indeterminate Pulmonary Nodule Malignancy Risk Assessment

The clinical management of patients with indeterminate pulmonary nodules is associated with unintended harm to patients and better methods are required to more precisely quantify lung cancer risk in this group. Here, we combine multiple noninvasive approaches to more accurately identify lung cancer...

Full description

Bibliographic Details
Main Authors: Kristin J. Lastwika, Wei Wu, Yuzheng Zhang, Ningxin Ma, Mladen Zečević, Sudhakar N. J. Pipavath, Timothy W. Randolph, A. McGarry Houghton, Viswam S. Nair, Paul D. Lampe, Paul E. Kinahan
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:Cancers
Subjects:
indeterminate pulmonary nodules
lung cancer
biomarkers
radiomics
semantic features
autoantibodies
Online Access:https://www.mdpi.com/2072-6694/15/13/3418

Internet

https://www.mdpi.com/2072-6694/15/13/3418

Similar Items